Law Firm Asks USPTO to Reexamine OGT's Foundational Patents for Undisclosed Client | GenomeWeb
A San Francisco law firm recently asked the US Patent and Trademark Office to reexamine two microarray patents held by Oxford Gene Technology, a UK array company that was founded as a IP-licensing firm but has broadened its portfolio over the past two years to offer microarray-based products and services.
The law firm Fliesler Meyer filed the ex parte reexamination requests in mid-January on behalf of a client who wishes to remain anonymous, according to Anthony Craig, an attorney at the firm.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.